Enoxaparin

The medicine enoxaparin.

  • Drug
  • In 2 atlases

Overview

Technical summary

RxNorm concept 67108 is the ingredient enoxaparin (term type IN). The federal Substance Registration System lists UNII E47C0NF7LV as the polymer substance ENOXAPARIN. MeSH descriptor D017984 is Enoxaparin. This identity is the substance only. It covers no dose, product, salt form or use, and the uses of enoxaparin belong to the interventions and recommendations that cite it.

Trials at a glance

The figures count the 16 registry trials in this atlas that name this drug or a product that contains it. Trials that use another name for it are not counted.

Trials
16
Phase 3 or 4
10
Recruiting
1
Regulatory decisions
0
Trials by phase (rows) and registry status (columns)
PhaseRecruitingCompletedUnknown statusAll statuses
Phase 1/20101
Phase 20404
Phase 2/31001
Phase 30112
Phase 40628
All phases112316

Conditions these trials study

Sponsors with the most trials

The lead sponsor of each trial, as the registry names it.

And 10 more.

About this drug

Level
Substance
Mechanism
Not reported

Claims and evidence

No claims are published for this drug yet.

Registry records

Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry trials 16

Record details

Record id
core:enoxaparin
Content hash
41f2fd7b83257bd5477f2a66ed8a930f4dd49ecd589c8642dbd4e7bff5cab602